文献速递胃肠外科围术期管理与 ERAS

阑尾神经内分泌肿瘤淋巴结转移风险与条件生存分析

Risk of lymph node metastases and conditional survival in appendiceal neuroendocrine neoplasms.
PubMed 文献 · Surgery · 2025-01-04

基于美国国家癌症数据库2010-2017年3541例I-III期阑尾神经内分泌肿瘤行结肠切除术患者,16%淋巴结阳性;浸润深度、淋巴血管侵犯和肿瘤大小与淋巴结转移相关;

要点

  • 阑尾神经内分泌肿瘤中约1/6存在淋巴结阳性,浸润深度、淋巴血管侵犯和肿瘤大小与淋巴结转移相关。
  • 浆膜穿透、混合性神经内分泌非神经内分泌肿瘤或杯状细胞癌组织学提示条件生存更差,需更密切随访。
  • 确定手术切除范围和监测策略时,除肿瘤大小外还应考虑上述额外因素。

核心结论

  • 全国队列中1/6阑尾神经内分泌肿瘤患者淋巴结阳性,与浸润深度、淋巴血管侵犯和肿瘤大小相关。
  • 浆膜穿透及混合性神经内分泌非神经内分泌肿瘤或杯状细胞癌组织学患者条件总生存更差,可能反映更具侵袭性的生物学行为。

研究设计与样本

  • 回顾性队列研究,利用美国国家癌症数据库2010-2017年接受结肠切除术的I-III期阑尾神经内分泌肿瘤成人患者,共3541例。
  • 纳入组织学包括神经内分泌瘤1级、神经内分泌瘤2和3级、神经内分泌癌、混合性神经内分泌非神经内分泌肿瘤及杯状细胞癌。

主要发现

  • 3541例患者中位年龄51岁,43%男性,88%白人,16%淋巴结阳性。
  • 组织学分布:神经内分泌瘤1级40%,神经内分泌瘤2和3级4%,神经内分泌癌10%,混合性神经内分泌非神经内分泌肿瘤12%,杯状细胞癌30%。

关键数值与推荐

  • NCCN指南推荐对>2.0 cm的阑尾神经内分泌肿瘤行节段性结肠切除术,因存在淋巴结受累风险。

临床怎么用

  • 确定手术切除范围时,除肿瘤大小外应综合考虑浸润深度、淋巴血管侵犯等淋巴结转移相关因素。
  • 对浆膜穿透、混合性神经内分泌非神经内分泌肿瘤或杯状细胞癌组织学患者,应考虑更密切的随访监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: National Comprehensive Cancer Network guidelines recommend segmental colectomy for appendiceal neuroendocrine neoplasms >2.0 cm given the risk for lymph node involvement. However, additional clinicopathologic factors are associated with nodal metastases, and thus survival. Given dynamic changes of prognosis over time, conditional overall survival, the probability of surviving after a specific interval, has emerged as a novel oncologic outcome, but is scarcely available for appendiceal neuroendocrine neoplasms. METHODS: Adults with stage I-III appendiceal neuroendocrine neoplasms who underwent colectomy from 2010-2017 were identified in the National Cancer Database. Tumor histologies included neuroendocrine tumor grade 1, neuroendocrine tumor grades 2 and 3, neuroendocrine carcinoma, mixed neuroendocrine non-neuroendocrine neoplasm, and goblet cell carcinoma. RESULTS: Of 3,541 patients (median age 51 years, 43% male, 88% White), 16% had positive lymph nodes. Overall, 40% had neuroendocrine tumor grade 1, 4% neuroendocrine tumor grades 2 and 3, 10% neuroendocrine carcinoma, 12% mixed neuroendocrine non-neuroendocrine neoplasm, and 30% goblet cell carcinoma. Increasing depth of invasion, lymphovascular invasion, and increasing size were associated with lymph node metastases. Eighty-seven percent were alive at 2 years. Mortality after 2 years was associated with older age, mixed neuroendocrine non-neuroendocrine neoplasm and goblet cell carcinoma histology, penetration through serosa, nodal involvement, and tumor size. CONCLUSIONS: In a national cohort, 1 in 6 patients had positive lymph nodes, which was associated with depth of invasion, lymphovascular invasion, and size. These findings indicate additional factors should be considered when determining the extent of surgical resection and surveillance to improve survival outcomes. Additionally, patients with penetration through serosa, and mixed neuroendocrine non-neuroendocrine neoplasm or goblet cell carcinoma histology had worse conditional overall survival, potentially reflecting more aggressive tumor biology that warrants closer follow-up.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Troester A, Weaver L, Frebault J, et al. Risk of lymph node metastases and conditional survival in appendiceal neuroendocrine neoplasms. Surgery. 2025. PMID: 39756338. doi:10.1016/j.surg.2024.109039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。